1-3 of 3
Lori Maness, M.D.
Close
Sort by
Journal Articles

A Retrospective Analysis Comparing BEAM Versus Melphalan Prior to First Autologous Peripheral Blood Hematopoietic Stem Cell Transplant in Newly Diagnosed Multiple Myeloma Patients

Edward Anthony Faber, Jr., DO, MS, Fausto R. Loberiza, Jr., MD, MS, Mojtaba Akhtari, Philip Bierman, MD, R. Gregory Bociek, MD, Lori Maness, M.D., Julie M Vose, MD
Journal: Blood
Blood (2011) 118 (21): 2040.
https://doi.org/10.1182/blood.V118.21.2040.2040
Published: 2011
Journal Articles

Trend Analysis of 5-Year All-Cause Mortality After Autologous Stem Cell Transplantation in Patients with Lymphoma and Multiple Myeloma

Mojtaba Akhtari, MD, James O. Armitage, Philip Bierman, MD, R. Gregory Bociek, MD, Edward Anthony Faber, Jr., DO, MS, Lori Maness, M.D., Julie M Vose, MD, Fausto R. Loberiza, Jr., MD, MS
Journal: Blood
Blood (2011) 118 (21): 842.
https://doi.org/10.1182/blood.V118.21.842.842
Published: 2011
Journal Articles

Marqibo ® (vincristine sulfate liposomes injection; VSLI) Optimizes the Dosing, Delivery, and Pharmacokinetic (PK) Profile of Vincristine Sulfate (VCR) In Adults with Relapsed and Refractory Acute Lymphoblastic Leukemia (ALL)

Jeffrey A Silverman, PhD, Walter E. Aulitzky, MD, John Lister, MD, Lori Maness, M.D., Gary J Schiller, MD, Karen Seiter, MD, Scott Smith, MD, PhD, FACP, Wendy Stock, MD, Dina Ben Yehuda, Steven R. Deitcher, MD
Journal: Blood
Blood (2010) 116 (21): 2142.
https://doi.org/10.1182/blood.V116.21.2142.2142
Published: 2010